Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits
Fierce Pharma
APRIL 30, 2024
Biopharma companies and industry lobbying groups are striking out in their legal efforts to challenge price-cutting measures in the Inflation Reduction Act. | A federal judge tossed lawsuits by Bristol Myers Squibb and Johnson & Johnson, which questioned the constitutionality of the U.S. government requiring drugmakers to negotiate with Medicare on drug pricing.
Let's personalize your content